About

Matthew Owen, PhD, is Associate Director, CMC and Pharmaceutical Sciences, at Kymanox, with extensive expertise in injectable, intranasal and inhalation drug product development. He specialises in complex injectable formulations, including polymeric microspheres, liposomes and lipid nanoparticles, as well as pulmonary and intranasal delivery systems, such as dry powders, nebulised formulations and nasal sprays. His background spans major CDMOs and academic institutions, with leadership across CMC strategy, analytical development and GMP manufacturing from preclinical through commercial
stages. He earned his PhD in Physical Chemistry from the University of California, Davis (CA, US),
and his BS in Chemistry from the University of California, Berkeley (CA, US).